Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	71.83	67.40	39.23
Graham Fair Price	-82.73	1011.84	5859.67
PEG	-127801.32	-4.45	< 0.005
Price/Book	7.46	2.18	2.03
Price/Cash Flow	-23.08	-21.02	27.33
Prices/Earnings	3528.92	431.12	11.88
Price/Sales	97.38	3.13	1.59
Price/FCF	-23.08	-21.02	27.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	29.11	0.17	0.13
Operating Margin	-3.20	0.06	0.06
ROA	-97.26	< 0.005	< 0.005
ROE	0.04	< 0.005	-97.04
ROIC	0.02	0.01	-50.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.11	0.44	-74.57
Dividends QOQ	0.00	8.29	100.00
EBIT QOQ	5.84	-0.47	-91.93
EPS QOQ	34.14	-0.97	-97.16
FCF QOQ	1.54	-2.40	56.44
Revenue QOQ	0.53	-0.45	-13.77
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	100.51	273.33	171.93
Days Sales Outstanding (DSO)	61.03	88.20	44.52
Inventory Turnover	0.90	0.33	-63.23
Debt/Capitalization	0.68	0.70	3.19
Quick Ratio	0.40	0.34	-15.67
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5978.35	5999.18	0.35
Cash	3141.79	3814.55	21.41
Capex	-175.62	-48.56	72.35
Free Cash Flow	443.84	-622.23	40.19
Revenue	7647.29	4177.87	-45.37
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.85	0.88	3.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.46	30.00	71.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating